Related Experiment Video

Updated: Oct 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

The Effect of Statin Therapy on Inflammatory Biomarkers: A Systematic Review

Matthew C Proute1, Nageshwar Kothur1, Petros Georgiou2,1

  • 1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus
|November 1, 2021
PubMed

Insights

Statins, or 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors, not only lower lipids but also reduce inflammation. This systematic review confirms their dual benefit in managing cardiovascular disease risk.

Area of Science:

  • Pharmacology
  • Cardiology
  • Biochemistry

Background:

  • Elevated lipid levels and cardiovascular disease are major health concerns.
  • Inflammatory biomarkers are crucial for monitoring cardiovascular disease progression and adverse event risk.
  • HMG-CoA reductase inhibitors are widely prescribed for lipid management.

Purpose of the Study:

  • To systematically review the anti-inflammatory effects of HMG-CoA reductase inhibitors.
  • To assess the impact of these drugs on inflammatory biomarkers in cardiovascular disease.

Main Methods:

  • A systematic literature search was performed using Medical Subject Headings (MeSH) across major databases.
  • Inclusion and exclusion criteria were applied to select relevant studies.
  • Twelve studies were included and assessed for risk of bias using the Cochrane risk analysis tool.

Main Results:

  • HMG-CoA reductase inhibitors demonstrated a significant lipid-lowering effect.
  • These inhibitors also exhibited a notable anti-inflammatory effect.
  • Most included studies had low risk of bias or some concerns regarding bias.

Conclusions:

  • HMG-CoA reductase inhibitors possess both lipid-lowering and anti-inflammatory properties.
  • These dual actions suggest a broader therapeutic role in cardiovascular disease management.
  • Further research may elucidate the full clinical implications of their anti-inflammatory effects.

Keywords:
atorvastatinerythrocyte sedimentation ratehigh-sensitivity c-reactive proteinhmg-coa reductase inhibitorsinflammatory biomarkerslovastatinpitavastatinpravastatinsimvastatinstatin therapy

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.5K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
950
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Inflammation01:38

Inflammation

Overview
56.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
259
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
745